Piotech (688072)2024-12-03 10:27Group 1: Investor Relations Activities - The company engaged in specific investor relations activities including analyst meetings and site visits [1] - Participating institutions included major securities firms and asset management companies [1][2] Group 2: Business Impact and Performance - The company confirmed that being added to the U.S. "Entity List" will not significantly impact its daily operations [3] - As of Q3 2024, the company reported a more than 160% year-on-year increase in shipment value [3][4] - The company anticipates a positive trend in new orders for 2024 based on strong contract liabilities and inventory [4] Group 3: Product Development and R&D - The company is expanding production of new products and technologies, including PECVD and ALD equipment [4][5] - R&D investment for Q3 2024 reached 481 million yuan, an increase of 126 million yuan year-on-year [5][6] - The company plans to maintain high R&D spending while keeping the R&D expense ratio at a healthy level [6] Group 4: Capacity and Infrastructure - The company has R&D and production bases in Shenyang, Shanghai, and Haining to meet current production needs [6] - A new factory in Shanghai is expected to be operational in the first half of 2025, enhancing production capacity [6]